Offering the latest insights into genomics, novel treatments, and genetic testing approaches shaping the future of inherited cardiac disease

Programme overview

This one-day course will provide attendees with updates in Inherited Cardiac Conditions with a focus on genomics and novel therapies for inherited cardiac disease.

Course aims/objectives

By the end of the meeting attendees will:

Have knowledge of novel therapies for treatment of hypertrophic cardiomyopathy and cardiac amyloidosis

Be able to appreciate how genetics influences diagnosis and management of inherited cardiac disease including polygenic scores, aortopathy and dilated cardiomyopathy.

Understand the benefits and limitations of risk assessment for risk stratification in dilated cardiomyopathy.

Be able to understand the benefits and drawbacks of screening in the general and specific populations.

A CPD accreditation will be applied for.

Who should attend

This in person meeting will bring together healthcare professionals working, training, and interested in inherited cardiac disease from Greater London and the South East region. All are welcome. This is a great opportunity to learn whilst networking with colleagues and friends.

Description supplied by the event organiser.